77 results about "Restriction Enzyme Site" patented technology

The invention relates to an establishment method of a long mate pair library. The establishment method comprises the steps as follows: 1) randomly interrupting DNA (deoxyribose nucleic acid), and completing and repairing the gaps at the tail end; 2) preparing A-Fragment; 3) carrying out cohesive end connection to A-Fragment and LMP Adaptor; 4) digesting the LMP-Adaptor-Fragment with at least two restriction enzymes which can distinguish four basic groups; 5) cyclizing the fragments in the obtained enzyme digesting library again; and 6) amplifying the purified ring molecule through primer of the LMP Adaptor; and recovering the amplified products, thus finishing the establishment of LMP (long mate pair) library. According to the library establishment method provided by the invention, only two 63bp oligonucleotides sequences are needed to be synthetized, and simple experiments such as molecular biology connection and amplification are carried out, and the two ends of the obtained LMP library have the sequencing primer sequences which can be directly applied to next generation sequencing; and moreover, the fragment subjected to secondary cyclizing has the known restriction enzyme site, and the sequences of two ends of the to-be-tested fragments can be quickly sorted, the sequence testing data can be effectively sieved, and the mosaic sequence can be removed.

The invention discloses an engineering bacterium through anthracene nucleus antibiotic and appliance, which is characterized by the following: inserting or replacing restriction enzymes site of dnmV gene nucleic acid order of sky blue rufus streptomycete with antibiotic against property gene and surface cerubidin synthetic gene; blocking-up engineering bacterium of dnmV gene; or transforming expressing carrier of anthracene nucleus antibiotic synthetic gene to lead streptomycin (S.lividans)TK24; extracting expressing plasmid from S.lividans TK24; leading-in sky blue rufus streptomycete gene only with antibiotic against property gene to block dnmV gene; blocking-up abrupt change bacterium. This invention can produce cerubidin and/or analogue, such as anthracene nucleus antibiotic.

The invention discloses an artificially cloned attenuated vaccine strains. The vaccine strains are strains cloned from attenuated vaccine strains HuN4-F112 of highly pathogenic porcine reproductive and respiratory syndrome virus (PRRSV), and marked restriction enzyme sites are introduced in the structural protein gene sequences of the strains. The invention also discloses a recombinant vector which comprises a full-length gene cDNA sequence of the attenuated vaccine strains HuN4-F112 of the highly pathogenic PRRSV. The 5'-end of the full-length gene cDNA sequence is additionally provided witha transcription promoter and the full-length gene cDNA sequence is internally introduced with the marked restriction enzyme sites. The artificially cloned attenuated vaccine strains of the invention can not only provide completely safe immune protection for resistance of an immune pig to the highly pathogenic PRRSV, but also effectively distinguish an immune pig of the PRRSV from a naturally infectious pig of the PRRSV, thus being beneficial to preventing and controlling the highly pathogenic PRRSV.

The invention discloses an inducible expression, purification and activity identification method of restructured lunasin polypeptide in pichia pastoris. The inducible expression and purification method includes 1) establishing the restructured expression plasmid: designing Lunasin sequence with EcoR I and Not I restriction enzyme sites, and designing specificity ampflification primer for PCR (polymerase chain reaction) amplification to obtain target gene segments; 2) screening high-resistance restructured gene engineering strains; 3) fermenting the restructured lunansin polypeptide; 4) separating and purifying the restructured lunansin polypeptide: obtaining the restructured lunasin polypeptide with purity at 93%. The pichia pastoris is firstly used to prepare lunasin polypeptide, and batch production of the lunasin polypeptide can be realized through the gene engineering method. The lunasin polypeptide expressed by the pichia pastoris is low in cost, and high in production, and separation and purification steps are simple.

The invention specifically relates to a Fab fragment of a fully-human recombinant anti-CD40L monoclonal antibody and a preparation method thereof, belonging to the field of genetic engineering technology. The Fab fragment comprises a heavy chain Fd and a light chain. During expression and preparation of the Fab fragment, a signal peptide PelB is added to the N terminal of the heavy chain Fd, and the C terminal of the heavy chain Fd is connected with a protease TEV restriction enzyme site and a histidine fusion tag; a signal peptide OmpA is added to the N terminal of the light chain; then a recombinant expression vector is constructed after connection with an Escherichia coli expression vector pETDuet-1 with double promoters; and the Fab fragment is further expressed and prepared. According to the invention, the Fab fragment is optimized and a host cell, the expression vector, expression conditions and purification conditions are reconstructed and optimized, so the Fab fragment is rapidly prepared, has the technical advantages of high purity, low cost, stable effect and the like and has good application value in prevention and control of related diseases.

The invention relates to an expression vector in the gene engineering field, and concretely relates to a vector for efficiently secreting and expressing a heterologous protein, and its application. An encoding signal peptide for efficiently secreting and expressing the heterologous protein is represented by a base sequence in SEQID NO.1. The vector for efficiently secreting and expressing the heterologous protein contains a specific nucleotide sequence, the sequence is the nucleotide sequence of a promoter and the encoding signal peptide; structure diagrams comprise a promoter sequence, a nucleotide sequence encoding the signal peptide, a 6*His tag sequence and a PmaCI restriction enzyme site; and the promoter is a T7 promoter, and the encoding signal peptide is a chitosan enzyme signal peptide of microbacterium (Microbacterium sp.OU01). The vector can efficiently secreting and expressing exogenous gene and also can effectively improve the water solubility of expression products, and a recombinant protein with biological activity can be obtained by using affinity chromatography one-step purification.

The invention relates to a modified retrotransposable element wherein one or more polyadenylation sites have been removed from within the genes of the retrotransposable element, and methods of use thereof. Sequences of optimized retrotransposable element are provided that have polyadenylation sites removed, and may be further modified to optimize codon usage for expression in mammals and to add restriction enzyme sites for ease of use.

It is an object of the present invention to provide an expression vector, a host, a fused protein, a protein, a process for producing a fused protein, and a process for producing a protein, which can prevent formation of an unactive abnormal protein at production of a recombinant protein, and can produce a desired protein as a natural type, that is, a soluble type at a large amount and effectively. That is, the present invention is an expression vector, which comprises: (a) a first coding region encoding a polypeptide having molecular chaperone activity, and (b) a region having at least one restriction enzyme site in which a second coding region encoding a protein can be inserted. In the expression vector of the present invention, the first coding region is operatively linked to a promoter, and the restriction enzyme sites are in the same reading frame as the first coding region, and are downstream of the first coding region, or the restriction enzyme sites are disposed so that the inserted second coding region is operatively linked to a promoter, and the first coding region is in the same reading frame as the second coding region, and is downstream of the second coding region.

The invention provides a method for cloning high-flux directed T vector. The method is as follows: an appropriate IIS type restriction enzyme site and lactose operator gene sequence (LacO) are selected; through reconstructing integrate lactose operator gene sequence (LacO) between vector mutagenesis cleavage joint transformation and cloning fragment, directed cloning and non-identification cloning are realized; moreover, fusion and non-fusion T vector construction is realized. The method has simple primer design, high cloning efficiency, less time consumption and low cost; moreover, the obtained recon does not need subsequent identification and is compatible with the prior cloning method.

The invention provides a chimeric polypeptide with dual-targeting function, and a preparation method and applications thereof. The chimeric polypeptide of the invention comprises three sequences with the following characteristics: sequence 1 is an amino acid sequence comprising the first 20-80 human lysozyme proteins counting from end N; sequence 2 is an amino acid sequence of Exendin-4 proteins; and sequence 3 is a connecting sequence of the sequence 1 and the sequence 2 and comprises a thrombin restriction enzyme site and a dipeptidyl peptidase restriction enzyme site. The chimeric polypeptide can be synthesized by using a polypeptide synthesizing technology, or can be obtained by constructing an expression carrier comprising the polypeptide nucleotide sequence specified by the code, expressing in a genetic engineering stain and finally purifying. The chimeric polypeptide of the invention has obvious dual-targeting activity for resisting AGEs and reducing blood sugar, and can be used for preparing medicines for resisting AGEs and/or lowering high blood sugar.

The invention relates to a method used to distinguish a sequence and a restriction enzyme cutting site of a canine distemper virus vaccine strain and a field strain and integrate two molecular biology test methods, namely RT-PCR and RFLP; a CDV NP gene is selected; a special primer is designed to amplify 829bp, and the segment is treated by BamHI RFLP; through agarose gel electrophoresis judgment, the canine distemper virus tested in the animal body is identified to belong to an inoculated vaccine strain or be injected by field virus from the number of segment; two segments 675bp and 153bp obtained from the electrophoresis are vaccine strains, and three segments 455bp, 220bp and 153bp are field strains. The method effectively distinguishes the canine distemper virus vaccine strain and the field strain, and provides veterinary technical guarantee for the cultivation of fur animals.

The present invention presents a Reverse Restriction Fragment Length Polymorphism (RRFLP) method for the detection of the presence of an informative restriction enzyme site in a nucleotide sequence. The method includes digesting a sample with the informative restriction enzyme; performing polymerase chain reaction (PCR) on the digested sample with an oligonucleotide primer pair that flanks the informative restriction enzyme site; determining the Ct value of the sample; comparing the Ct value of the sample to the Ct value from a control sample; and calculating a ΔCt value, wherein a ΔCt value is the Ct value of the sample minus the Ct value of a control; and wherein a ΔCt value ≧+1 indicates that the informative restriction enzyme sites is present in the nucleotide sequence. The present invention includes the application of the RRFLP method for detection of the infectious laryngotracheitis virus (ILTV).

The invention belongs to the technical field of genetic engineering and discloses a method for quickly constructing a recombinant plasmid; the method comprises the steps of designing homologous recombinant primers, preparing E. coli competent cells carrying pKD46 plasmid, and co-converting an exogenous DNA fragment having sections homologous to the plasmid. An E. coli strain with Red recombinant system is constructed by using pKD46 plasmid to stably express Red recombinase under the induction of L-arabinose, the recombinase is capable of promoting the sections homologous to the plasmid and carried to two ends of the exogenous DNA fragment to recombine with a linear plasmid, it is achieved for the first time that an exogenous DNA fragment is inserted into a single limited restriction enzymes site of a support by means of RED recombination technology, it is possible to eliminate pKD46 plasmid by cultivation at 37 DEG C, no disturbance is caused to subsequent experiments, the construction steps of the recombinant plasmid are greatly simplified, and construction time is shortened. The produced recombinant plasmid is verified via PCR (polymerase chain reaction) and enzyme digestion to exhibit high positive cloning efficiency, and the method may act as a new means to construct a recombinant plasmid.

The present invention provides a rabies virus CTN strain whole genome cDNA infectious clone, as well as a method of using reverse genetics technology to save the active rabies virus. The present inventive method includes: using the single restriction enzyme sites in the CTN strain of rabies virus full-length genome to divide the full-length virus into four segments to amplify, simultaneously using the green fluorescent protein gene to substitute 423bp base at the pseudo-gene point, cloning in the pVAX-R expression vector, to construct a recombinant full-length plasmid of the virus genome; performing PCR amplification of nucleoprotein, phosphoprotein, glycoprotein and transcription large protein gene sequence of the CTN strain of the rabies virus, and cloning the amplified fragment into a vector pVAX1, to constitute four auxiliary plasmids in the reverse heredity system; and then using the five plasmids to jointly transfect cells, to rescue the rabies virus. The present invention successfully saves the rabies virus, and has a great significance in the study of the pathogenic mechanism of rabies virus, development of new vaccines, viral vectors and the like areas.

The present invention belongs to the field of animal disease detection technology, specifically to the field of cattle recessive genetic disease spondyle malformation syndrome (CVM) detection, includes steps as follows: extracting cattle genome DNA from the cattle sample to be tested, designing the PCR amplification prime pair intruding the restriction enzyme site and performing the PCR reaction based on the cattle SLC35A3 gene sequence, using 2.5% agarose gel electrophoresis to test the PCR amplification products, dyeing, observing bands in the gel imaging system, recovering the PCR products to perform restriction enzyme, performing electrophoresis detection in 10% polyacrylamide gel after the reaction is completed, determining the genetype of the tested sample according to the band distribution of the amplification products.

The invention discloses a vector recombination and construction method, a photosynthetic bacteria rhodopseudomonas palustris fluorescent GFP marker vector construction and electrotransformation method. The recombinant vector includes the photosynthetic bacteria rhodopseudomonas palustris fluorescent GFP marker vector including a PBBR1MCS-2 shuttle vector and a full-length fragment of a green fluorescent protein marker gene GFP, and is fused with a photosynthetic bacteria genome expression promoter PpckA gene and terminator TpckA gene, as well as a widely applied GFP gene, and a full-length fragment sequence of the GFP gene; the full-length fragment of the GFP gene is located between two ECORI and SACI restricted restriction enzyme sites of the PBBR1MCS-2 shuttle vector. The construction method includes the steps: genome DNA extraction, primer designing, PCR amplification, enzyme digestion, connection and other steps. The invention also includes obtained engineering bacteria containingthe recombinant vector, wherein the engineering bacteria are obtained by electrotransformation of the recombinant vector into competent cells. The engineering bacteria have the advantages of high stability, simple technology and environmental friendliness, and can be applied for study of a colonization behavior of photosynthetic bacteria in plants.

The present invention discloses a construction method of an HIV-1 integrase mutant library. The method comprises the following elements: (1) manufacturing gaps on random sites of a target gene by using transposition of transposon and restriction enzyme on both ends of the transposon, inserting mutation insertion boxes, using the restriction enzyme sites on the box to achieve replacement of three bases on the gene through digestion self-connection, and translating the target gene into protein to cause mutation o one or two consecutive amino acids on the target protein; and (2), using site-directed mutagenesis PCR to realize mutation of three bases, for the replacement of the original target gene and on the inserted mutation insertion boxes, from codons encoding cysteine into codons encoding other 19 amino acids, thereby increasing the diversity of the final mutant library.

The invention provides a bran coat source peroxidase anti-tumor active fragment as well as a preparation method and application thereof. The preparation method of the fragment comprises the followingsteps: extracting mRNA of rice seedling tissues by a Trizol method, taking the mRNA as a template, performing enzymatic catalysis, and performing inverse transcription to obtain cRNA; obtaining a protein gene sequence in Genebank according to FMBP mass spectrum identification results of the rice anti-tumor active protein, respectively performing truncated screening according to different functional regions, determining a gene sequence of Ca<2+> binding sites as an anti-tumor effect structural domain, and designing a specific primer thereby; taking the rice cDNA as a template, and amplifying the FMBP-C gene sequence by a PCR (Polymerase Chain Reaction) method; respectively introducing BamH I and HindIII restriction enzyme sites at the upstream and downstream of the sequence, connecting thesites with a pMal-s vector, constructing a pMal-s-FMBP-C recombinant plasmid, transferring E.coli DH5alpha competent cells, and screening to obtain a positive transformant; performing induced expression on a target protein through IPTG (Isopropyl Thiogalactoside), performing affinity purification, desalting and concentrating, and detecting functions of resisting tumors and reversing multiple drugresistance of tumors by an MTT method. The results show that the active fragment has obvious activities of resisting tumors and reversing multiple drug resistance of the tumors.

The invention provides a pre-T-vector, which is prepared by the following method. (1) Plasmids of resistant genes of sensitive antibiotics of escherichia coli without containing ampicillin are taken as templates to conduct PCR amplification; XcmI restriction enzyme sites are introduced into terminals of a primer 5`; and DNA fragments are obtained by amplification which contain the resistant genes of the antibiotics, and the upstream and the downstream of the DNA fragment express regulation sequences, and the two terminals of the DNA fragment contain the XcmI restriction enzyme sites. (2) The DNA fragments obtained in procedure (1) are connected with a pUCmT vector by a joining enzyme T4DNA. (3) The connected product obtained in procedure (2) is transformed into escherichia coli DH5 Alpha or JM109; and positive clones are screened, and then the pre-T-vector can be obtained. The pre-T-vector has the following advantages that vectors prepared by the pre-T-vector can be used to clone the product PCR quickly, and X-gal is not needed in the process of screening the positive clones with low negative rate.

The invention discloses a method for efficiently constructing a T vector based on the PCR method. The main method is to introduce a pair of oligonucleotide fragments containing a specific restriction enzyme site into the starting vector (such as pUC18). The restriction enzyme site is characterized by The corresponding enzyme (such as EcoRV) can produce blunt ends, and the bases before and after the cutting point are T and A, respectively. Then use the enzyme to linearize the starting vector as a PCR template, design primers to generate a single strand through single primer PCR amplification or asymmetric PCR amplification, and then anneal the two single strands to form a T vector. The preparation of the T vector by the method is simple and fast, and the prepared T vector can efficiently clone the PCR product with an "A" tail, and its non-recombination background is almost zero.

Antibody expression vectors and plasmids can incorporate various antibody gene portions for transcription of the antibody DNA and expression of the antibody in an appropriate host cell. The expression vectors and plasmids have restriction enzyme sites that facilitate ligation of antibody-encoding DNA into the vectors. The vectors incorporate enhancer and promoter sequences that can be varied to interact with transcription factors in the host cell and thereby control transcription of the antibody-encoding DNA. A kit can incorporate these vectors and plasmids.